Neoadjuvant Therapy in Cervical Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Neoadjuvant Therapy in Cervical Cancer — Stella

Home/Uterine Cervical Neoplasms/

View on ClinicalTrials.gov

Recruiting

Back to Uterine Cervical Neoplasms trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Qilu Hospital of Shandong University, Jinan, Shandong

Key details

Sponsor

Qilu Hospital of Shandong University

Collaborators

RemeGen Co., Ltd.

Enrollment target

~48 participants

Started

October 2024

Primary completion

October 2026

Age range

18 Years – 70 Years

Sex

Female only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.